PRJQX
Price
$49.96
Change
+$0.20 (+0.40%)
Updated
Dec 3 closing price
Net Assets
6B
RNPCX
Price
$71.95
Change
+$0.37 (+0.52%)
Updated
Dec 3 closing price
Net Assets
162.64B
Interact to see
Advertisement

PRJQX vs RNPCX

Header iconPRJQX vs RNPCX Comparison
Open Charts PRJQX vs RNPCXBanner chart's image
PGIM Jennison Global Opportunities R6
Price$49.96
Change+$0.20 (+0.40%)
VolumeN/A
Net Assets6B
American Funds New Perspective R3
Price$71.95
Change+$0.37 (+0.52%)
VolumeN/A
Net Assets162.64B
PRJQX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
PRJQX vs. RNPCX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRJQX is a StrongBuy and RNPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 163B vs. PRJQX (6B). RNPCX pays higher dividends than PRJQX: RNPCX (0.21) vs PRJQX (0.00). PRJQX was incepted earlier than RNPCX: PRJQX (11 years) vs RNPCX (24 years). RNPCX (1.06) is less costly to investors than PRJQX (0.82). PRJQX is a more actively managed with annual turnover of: 66.00 vs. RNPCX (24.00). PRJQX has a lower initial minimum investment than RNPCX: PRJQX (0) vs RNPCX (250). RNPCX annual gain was more profitable for investors over the last year : 11.50 vs. PRJQX (-0.75). RNPCX return over 5 years is better than : 22.60 vs. PRJQX (10.19).
PRJQXRNPCXPRJQX / RNPCX
Total Expense Ratio0.821.0677%
Annual Report Gross Expense Ratio0.821.0677%
Fund Existence11 years24 years-
Gain YTD8.35019.77742%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6B163B4%
Annual Yield % from dividends0.000.21-
Returns for 1 year-0.7511.50-7%
Returns for 3 years65.3243.97149%
Returns for 5 years10.1922.6045%
Returns for 10 years210.8990.03234%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATNM1.450.07
+5.07%
Actinium Pharmaceuticals
AXSM147.815.72
+4.03%
Axsome Therapeutics
ARLO14.270.38
+2.74%
Arlo Technologies
TLSI6.43-0.02
-0.31%
TriSalus Life Sciences
MNSBP24.85-0.12
-0.50%
MainStreet Bancshares